Log in
Enquire now
‌

US Patent 11236096 Fused pyrimidine compound or salt thereof

Patent 11236096 was granted and assigned to Taiho Pharmaceutical on February, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Taiho Pharmaceutical
Taiho Pharmaceutical
Current Assignee
Taiho Pharmaceutical
Taiho Pharmaceutical
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11236096
Patent Inventor Names
Tadashi Shimamura0
Hidenori Fujita0
Isao Miyazaki0
Masanori Kato0
Date of Patent
February 1, 2022
Patent Application Number
16855332
Date Filed
April 22, 2020
Patent Primary Examiner
‌
Susanna Moore
Patent abstract

The present invention provides a novel RET inhibitor comprising, as an active ingredient, a compound or a salt thereof that have not been known for their RET inhibitory activity, and also provides an agent for preventing or treating diseases (e.g., malignant tumors) that can be prevented or treated by RET inhibitory activity. The RET inhibitor comprises, as an active ingredient, a compound represented by Formula (I) below or a salts thereof:

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11236096 Fused pyrimidine compound or salt thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.